Clinical Trial

Cardiovascular Complications of Sickle Cell Disease

Study Description

Cardiovascular Complications of Sickle Cell Disease

In this research study, we are using heart imaging exams and blood testing, in order to gain an improved understanding of the pulmonary (lung) hypertension and cardiovascular (heart) complications that often occur in sickle cell patients. Information gathered from the healthy volunteers that participate in this study will be compared to information from the sickle cell patients in this study in order to help further our understanding.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Procedure - MRI, Transthoracic Echocardiography, tonometry, EKG

Unless contraindicated, subjects will receive Regadenoson and Gadolinium contrast agent during the Cardiac magnetic resonance. The tonometer, EKG, and echo are non-invasive procedures.

Additional Information

Official Study Title

Cardiovascular Complications of Sickle Cell Disease

Clinical Trial ID

NCT01044901

ParticipAid ID

1aMj3b